The University of Texas Health Science Center at San Antonio
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center at San Antonio sits in the top decile of US sponsors by registered trial count (#94 of 15,742 sponsors by registered trial count).
The University of Texas Health Science Center at San Antonio: 378 sponsored US clinical trials, 77 recruiting.
The University of Texas Health Science Center at San Antonio sponsors 378 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 264 completed. 41 of these trials are in Phase 3-4 (later-stage) and 124 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.
Top-decile sponsor footprint
The University of Texas Health Science Center at San Antonio ranks in the top decile of sponsors by registered trial count (#94 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
264 of 284 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
378 total, page 1 of 8
SGLT2i, Pioglitazone, and Ketone Production in T2D
NCT07053319
The Effects of Stellate Ganglion Block Sleep in U.S. Active Duty Service Members and Veterans Receiving Prolonged Exposure Therapy for PTSD
NCT07667309
TMS for PTSD in Youth
NCT07401225
Oil Pulling Whitening Mouthwash
NCT07667088
Impact of Ketogenic Diet on Tumor Microenvironment in Patients With Breast Cancer
NCT07574671
Home-Based Heat Therapy in Spinal Cord Injury to Improve Cardiovascular Health
NCT07317843
Non-Trauma Intervention to Treat PTSD for Veterans and Service Members Suffering From a TBI
NCT07351305
Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma
NCT07340151
Sensing in Sleep Deep Brain Stimulation
NCT07636720
The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery
NCT07212868
TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study
NCT06580509
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
NCT06811324
Quitxt Mobile Text Messaging Cessation Research Study
NCT05958667
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
NCT07176273
Wound Healing Following Tooth Extraction and Ridge Preservation Using OsteoGen®
NCT07154693
Ultrasound for Healthy Aging
NCT07168525
Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy
NCT07137871
Home-based TDCS (Transcranial Direct Current Stimulation) for Cognitive and Behavioral Symptoms in Huntington's Disease
NCT06843252
The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness
NCT07053969
Microsurgery and Periodontal Healing
NCT07054008
RESTOR: PK/PD mTORi Inhibition in Older Adults
NCT06658093
Treatment for PTSD and Tinnitus
NCT07106593
Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms
NCT06801639
Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)
NCT06977711
Shared Decision Making in PTSD Treatment
NCT06953687
SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia
NCT07053306
Treatment of Chronic Anger and Aggression Following Military-Related Betrayal
NCT06609330
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
NCT06745947
Image-guided, Robot Navigated Transcranial Magnetic Stimulation (IR-TMS) for Alcohol Use Disorder (AUD)
NCT06648642
Evaluation of the Integrated Smart Pump-EHR Technology in Eight Adult Acute and Intensive Care Units
NCT06695169
Phosphatidylethanol and Other Ethanol Consumption Markers
NCT06747364
SGLT2i, Hepatic Glucose Production, and SNS
NCT07053293
Blood Flow Restriction for Optimizing Balance in Parkinson's Disease
NCT06508801
Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma
NCT06516887
Behavioral Insomnia Treatment in Mild Traumatic Brain Injury
NCT06551987
Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
NCT06526104
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
NCT06246799
Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis
NCT05705414
Closed Sinus Augmentation With a Calcium Phosphosilicate Putty
NCT06507709
Mirragen Diabetic Foot Ulcer Study
NCT06598241
Auditory Plasticity Training
NCT06628505
Prevention of Progression of Prediabetes, Obesity and CV Risk
NCT06446531
δ in Dementia Clinical Trials
NCT05592678
KIOS Mobile App Evaluation
NCT06212557
Combining Stellate Ganglion Block With Prolonged Exposure for PTSD
NCT05889741
Endurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD
NCT06133283
Ketones, SGLT2, HFrEF
NCT06229678
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
NCT06108076
SGLTi, Hepatic Glucose Production and Ketogenesis
NCT05960656
Multisite Advancement of Research on Chronic Posttraumatic Headache
NCT05620719
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 45 |
| Phase 3 | 8 |
| Phase 4 | 33 |
Therapeutic Areas
What is open in the The University of Texas Health Science Center at San Antonio pipeline
77 recruiting of 378 indexed (20% open); 264 completed (70%).
Phase mix: 41 late (III/IV) vs 124 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Health Science Center at San Antonio: open-pipeline peers nationwide
Peers matched on 378 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
The University of Texas Health Science Center at San Antonio sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 378 trials (± recruiting share)
- Northwell Health · 370 trials · 22% recruiting
- University of California, Irvine · 368 trials · 20% recruiting
- UNC Lineberger Comprehensive Cancer Center · 366 trials · 22% recruiting
- Roswell Park Cancer Institute · 365 trials · 16% recruiting
Sponsors near 20% open enrollment (± trial volume)
- M.D. Anderson Cancer Center · 20% recruiting · 2,692 trials
- University of Georgia · 20% recruiting · 59 trials
- University of Houston · 20% recruiting · 64 trials
- Florida International University · 20% recruiting · 89 trials
Related
What to do with this The University of Texas Health Science Center at San Antonio page
378 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center at San Antonio or any single study.
- 77 of The University of Texas Health Science Center at San Antonio's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition The University of Texas Health Science Center at San Antonio studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
The University of Texas Health Science Center at San Antonio pipeline card: 378 registered trials from official public datasets.Report a data error.